Article citationsMore>>

Li, N., Zhou, J., Chen, R., Zhao, X., Li, J., Zhou, P., et al. (2023) Prognostic Impacts of Diabetes Status and Lipoprotein(a) Levels in Patients with St-Segment Elevation Myocardial Infarction: A Prospective Cohort Study. Cardiovascular Diabetology, 22, Article No. 151.
https://doi.org/10.1186/s12933-023-01881-w

has been cited by the following article:

• TITLE: Research Progress on Inflammation-Related Biomarkers for Prognosis after Emergency PCI in STEMI Patients

  AUTHORS: Zhengkui Qin, Xiuge Tang

  KEYWORDS: Acute ST-Segment Elevation Myocardial Infarction (STEMI), Percutaneous Coronary Intervention (PCI), Inflammatory Biomarkers, Disease Prognosis, Major Adverse Cardiovascular Events (MACE)

  JOURNAL NAME: World Journal of Cardiovascular Diseases, Vol.16 No.6, June 22, 2026

  ABSTRACT: Although emergency percutaneous coronary intervention (PCI) can rapidly restore myocardial perfusion in patients with acute ST-segment elevation myocardial infarction (STEMI), these patients still face a relatively high risk of major adverse cardiovascular events (MACE) after the procedure. The inflammatory response plays a central role in myocardial injury, ventricular remodeling, and thrombosis following STEMI. This article reviews the predictive value of inflammation-related biomarkers—including C-reactive protein, fibrinogen, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammatory response index, and red cell distribution width—for prognosis after emergency PCI in STEMI patients, aiming to provide a reference for clinical risk assessment and stratification.